文献速递眼底病与葡萄膜炎神经眼科角膜与眼表疾病

在主要为代表性不足人群中角膜敏感性与糖尿病视网膜病变严重程度呈负相关

Corneal Sensitivity Is Inversely Correlated With Severity of Diabetic Retinopathy in a Predominantly Underrepresented Population.
PubMed 文献 · Am J Ophthalmol · 2023-08-27

这项前瞻性研究纳入50例来自主要为代表性不足种族和族裔背景的糖尿病视网膜病变(DR)患者的100只眼,用Cochet-Bonnet触觉计评估角膜敏感性,并由设盲的阅读中心对DR严重程度分级。当前或既往增殖性DR(PDR)眼的中位角膜敏感性为0.5 cm,而无当前或既往PDR眼为4.75 cm(P < .0001);抗VEGF治疗后PDR消退眼的中位角膜敏感性为0 cm,与未治疗PDR眼无差异。DR严重程度量表评分≥60分的眼发生完全角膜敏感性丧失的比值是非增殖性DR眼的3.6倍。

要点

  • 当前或既往PDR眼的中位角膜敏感性为0.5 cm,显著低于无当前或既往PDR眼的4.75 cm(P < .0001)。
  • 抗VEGF治疗后PDR消退眼的中位角膜敏感性为0 cm,显著低于无当前或既往PDR眼的4.5 cm(P = .0076),与未治疗PDR眼无差异。
  • DR严重程度量表评分≥60分的眼发生完全角膜敏感性丧失的比值是非增殖性DR眼的3.6倍。

核心结论

  • 与NPDR眼相比,PDR眼的角膜敏感性受损,且抗VEGF治疗未能使其恢复。
  • 评估DR眼的角膜敏感性可能识别出存在其他并发症(包括神经营养性角膜病变)风险的患者。

研究设计与样本

  • 前瞻性研究,纳入50例来自主要为代表性不足种族和族裔背景的DR患者的100只眼。
  • 使用Cochet-Bonnet触觉计评估角膜敏感性,DR严重程度由设盲的阅读中心分级。
  • 比较当前或消退性PDR眼(n=35)与无PDR史的NPDR眼(n=65)的角膜敏感性。
  • 比较抗VEGF治疗后从PDR消退为NPDR的眼(n=7)与无当前或既往PDR的未治疗眼(n=55)及新诊断未治疗PDR眼(n=12)。

主要发现

  • 当前或既往PDR眼的中位角膜敏感性(4个象限平均值)为0.5 cm(IQR 0-3.375),无当前或既往PDR眼为4.75 cm(IQR 2.0-6.0),P < .0001。
  • PDR消退眼的中位角膜敏感性为0 cm(IQR 0-0.875),显著低于无当前或既往PDR眼的4.5 cm(IQR 4.0,P = .0076),与未治疗PDR眼的0 cm(IQR 1.25)无差异。
  • DR严重程度量表评分≥60分的眼发生完全角膜敏感性丧失的比值为NPDR眼的3.6倍。

关键数值与推荐

  • 当前或既往PDR眼的中位角膜敏感性为0.5 cm(IQR 0-3.375),无当前或既往PDR眼为4.75 cm(IQR 2.0-6.0),P < .0001。
  • PDR消退眼的中位角膜敏感性为0 cm(IQR 0-0.875),无当前或既往PDR眼为4.5 cm(IQR 4.0),P = .0076。
  • 未治疗PDR眼的中位角膜敏感性为0 cm(IQR 1.25)。
  • DR严重程度量表评分≥60分的眼发生完全角膜敏感性丧失的比值为NPDR眼的3.6倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the relationship between diabetic retinopathy (DR) and corneal sensitivity. METHODS: In this prospective study, 100 eyes of 50 patients from primarily underrepresented racial and ethnic backgrounds with DR underwent assessment of corneal sensitivity using a Cochet-Bonnet esthesiometer. Severity of DR was graded by a masked reading center. Corneal sensitivity was compared in eyes with current or regressed proliferative DR (PDR) (n=35) and eyes with nonproliferative DR (NPDR) with no history of PDR (n=65). Corneal sensitivity in eyes that regressed from PDR to NPDR with anti-vascular endothelial growth factor (anti-VEGF) therapy (n=7) was compared to treatment-naïve eyes with no current or prior PDR (n=55) and to eyes with newly diagnosed, treatment-naïve PDR (n=12). RESULTS: In eyes with current or prior PDR, the median corneal sensitivity (average of 4 quadrants) was 0.5 cm (interquartile range [IQR] 0-3.375), whereas in eyes with no current or prior PDR, the median corneal sensitivity was 4.75 cm (IQR 2.0-6.0, P < .0001). The median corneal sensitivity in eyes with regressed PDR was 0 cm (IQR 0-0.875), significantly lower than eyes with no current or prior PDR (4.5 cm, IQR 4.0, P = .0076) and no different than eyes with untreated PDR (0 cm, IQR 1.25). The odds of eyes with DR severity scale score ≥60 having complete corneal sensitivity loss was 3.6 times that of eyes with NPDR. CONCLUSIONS: Corneal sensitivity is impaired in eyes with PDR compared to NPDR and is not rescued by anti-VEGF therapy. Assessment of corneal sensitivity in eyes with DR may identify patients at risk for additional complications, including neurotrophic keratopathy. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Singer M, O'Brien P, Mein L, et al. Corneal Sensitivity Is Inversely Correlated With Severity of Diabetic Retinopathy in a Predominantly Underrepresented Population. Am J Ophthalmol. 2023. PMID: 37643714. doi:10.1016/j.ajo.2023.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。